Phase I study to evaluate the excretion of radioactivity, the metabolic profile, pharmacokinetics, safety and tolerability following a single oral administration of \[14C\] SPD557 in healthy male volunteers aged 18 to 50 years (inclusive).The purpose of this study is to investigate how and how quickly SPD557 or its break down products are excreted by analysing blood, faeces and urine samples collected during the study.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
6
A single oral dose of 2 mg radiolabeled SPD557 administered on Day 1
Covance
Madison, Wisconsin, United States
Area Under the Plasma Concentration Versus Time Curve From Time Zero to Infinity (AUC 0→∞) of Radiolabelled SSP-002358
Area under the plasma concentration versus time curve from time 0 to infinity. AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body.
Time frame: Over 240 hours post-dose
Maximum Plasma Concentration (Cmax) of Radiolabelled SSP-002358
Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administered.
Time frame: Over 240 hours post-dose
Time to Maximum Plasma Concentration (Tmax) of Radiolabelled SSP-002358
Time frame: Over 240 hours post-dose
Plasma Half-Life (T1/2) of Radiolabelled SSP-002358
Time frame: Over 240 hours post-dose
AUC 0→∞ Whole Blood Total Radioactivity of Radiolabelled SSP-002358
Time frame: Over 240 hours post-dose
Cmax Whole Blood Total Radioactivity of Radiolabelled SSP-002358
Time frame: Over 240 hours post-dose
Tmax Whole Blood Total Radioactivity of Radiolabelled SSP-002358
Time frame: Over 240 hours post-dose
Half-Life Whole Blood Total Radioactivity of Radiolabelled SSP-002358
Time frame: Over 240 hours post-dose
AUC 0→∞ Plasma Total Radioactivity of Radiolabelled SSP-002358
Time frame: Over 240 hours post-dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cmax Plasma Total Radioactivity of Radiolabelled SSP-002358
Time frame: Over 240 hours post-dose
Tmax Plasma Total Radioactivity of Radiolabelled SSP-002358
Time frame: Over 240 hours post-dose
Half-Life Plasma Total Radioactivity of Radiolabelled SSP-002358
Time frame: Over 240 hours post-dose
Percent Total Radioactivity Excreted in Urine of Radiolabelled SSP-002358
Time frame: Over 240 hours post-dose
Percent Total Radioactivity Excreted in Stool of Radiolabelled SSP-002358
Time frame: Over 240 hours post-dose